Key HighlightsLiquidia (NASDAQ:LQDA) booked a USD 389.7 million litigation settlement charge that turned USD 222.7 million of product sales into aGAAPnet loss of USD 236.3 million.Opus Genetics (NASDAQ:IRD) lost USD 46.5 million, of which USD 28.6 million was a non-cashFair Valuecharge on warrants and …
Key HighlightsVeradermics (NYSE:MANE) held USD 798.4 million in cash, equivalents and marketable securities, which management believes funds operating expenses andCapitalneeds into 2030.Metagenomi Therapeutics (NASDAQ:MGX) reported collaborationRevenueof USD 2.18 million against USD 8.66 million a year earlier, and the FDA cleared its MGX-001 application in …
Key HighlightsPalisade Bio (NASDAQ:PALI) reportedResearch and Developmentexpense up 659% to USD 10.6 million, with cash of USD 113.6 million that management believes funds operations through both Phase 2 readouts.Ovid Therapeutics (NASDAQ:OVID) lost USD 20.8 million against USD 12.2 million and held USD 161.4 million, …
Key HighlightsSionna Therapeutics (NASDAQ:SION) held USD 249.8 million at September 30, 2026 after cutting about 46% of its workforce, and says that cash funds operations into the second half of 2029.PMV Pharmaceuticals (NASDAQ:PMVP) cut operating expenses to USD 20.1 million from USD 22.5 million, …
Key HighlightsTyra Biosciences (NASDAQ:TYRA) held USD 700.5 million at September 30, 2026, which it says funds operating expenses and capital expenditures through 2030, while its third-quarter net loss rose to USD 51.1 million.Upstream Bio (NASDAQ:UPB) held USD 207.4 million, which it says funds operations …
Key HighlightsAnteris Technologies Global (NASDAQ:AVR) held USD 236.3 million of cash and restricted cash at September 30, 2026 against a third-quarter net loss of USD 26.8 million.Bionano Genomics (NASDAQ:BNGO) ended the quarter with USD 8.7 million of cash, cash equivalents and securities, and the …
Key HighlightsFreenome (NASDAQ:FRNM) reported third-quarterGAAPNet Incomeof USD 60.1 million against a USD 64.5 million loss, after USD 180.0 million was recognized under its license agreement following FDA approval of SimpleScreen CRC.Lumexa Imaging (NASDAQ:LMRI) swung to net income of USD 7.2 million from a USD …
Key HighlightsPrecipio (NASDAQ:PRPO) cut its third-quarter net loss to USD 8,000 from USD 79,000 on net sales of USD 7.3 million, while its filing saysGoing Concernstatus depends on achieving its plan.Orchestra BioMed (NASDAQ:OBIO) closed an offering of 17,250,000 shares at USD 5.00 on November …
Key HighlightsSANUWAVE Health (NASDAQ:SNWV) reported UltraMIST systemRevenuedown about 73% to USD 1.2 million, dragging third quarter revenue down 24% to USD 8.579 million.Seer (NASDAQ:SEER) lowered 2026 revenue guidance to USD 13.5 million to 14.5 million from USD 16 million to 18 million after third …
Key HighlightsExagen (NASDAQ:XGN) reported a record trailing 12-month average selling price of USD 451 per AVISE CTD test, the 14th consecutive quarterly improvement, onRevenueof USD 18.4 million.TELA Bio (NASDAQ:TELA) cut its adjusted EBITDA loss 40% to USD 3.4 million while revenue fell 8% to …